GSK has told Simcere they have got zanamivir for free for China and half of Asia because of the dire need for Relenza. The only reason there is a dire need for Relenza is because behind the bullsh!t GSK crows about the "GSK increase production of Relenza" there aren't any GSK Relenza ACTUAL PRODUCTION FIGURES, only GSK 100% concentrating on making and selling GSK VACCINES, and GSK treats Relenza as the enemy which is easy for GSK, because Biota management are spineless selfish, ignorant jellyfish, who work as GSK's hand puppets anyway.
Old Biota shareholders stand about, tired of Biota disapointment, but hope some newbies will start the pump "one more try"and launch the share price to where everyone thinks it should be anyway. It can't be Biota management or GSK scams, surely not?
So Roche gets rich, GSK get rich, Biota management get rich, Simcere get rich, and Biota shareholders are forced to be noble about saving lives, because we're shafted by EVERY BODY, and pay money to Biota for the privilege
BTA Price at posting:
$1.20 Sentiment: Hold Disclosure: Held